Correlation Engine 2.0
Clear Search sequence regions


  • humans (1)
  • hydrolysis (1)
  • mitosis (3)
  • oxygen (3)
  • research (2)
  • species (3)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    Exploiting universal cancer vulnerabilities has been used as an approach for developing targeted therapies. In this issue of Cancer Research, Rudd and colleagues show that the dual-functioning inhibitor TH588 potentiates the accumulation of reactive oxygen species during mitosis in cancer by disturbing mitotic progression and simultaneously inhibiting the hydrolysis of 8oxodGTP. This leads to increased incorporation of 8oxodG into the DNA during mitotic replication and increased toxicity. Understanding the mechanism of this inhibitor lays the groundwork for identifying cancer targets.See related article by Rudd et al., p. 3530. ©2020 American Association for Cancer Research.

    Citation

    Khadijeh Alnajjar, Joann B Sweasy. Timing Is Everything: Misincorporation of 8oxodG during Mitosis Is Lethal. Cancer research. 2020 Sep 01;80(17):3459-3460

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32878864

    View Full Text